Skip to content

The effect of tapering tumor necrosis fator inhibitor on disease activity and radiographic progression in axial spondyloarthritis

The effect of tapering tumor necrosis fator inhibitor on disease activity and radiographic progression in axial spondyloarthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043491
Enrollment
Unknown
Registered
2021-02-21
Start date
2021-02-20
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

axial spondyloarthritis

Interventions

tapering group:patients treated with tapering tumor necrosis factor inhibitors
withdrawal group:patients treated with tumor necrosis factor inhibitors for few months
NSAIDs group:1. Those who are allergic to TNFi
2. Patients with active hepatitis B, tuberculosis and other infectious diseases
3. Pregnant patients
4. Patients with severe infections

Sponsors

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 and <= 70 years (until the date of screening); 2. Meet the 2009 ASAS Axial SpondyloArthritis Classification Standard; 3. Patients treated with tumor necrosis factor inhibitors or non-steroidal anti-inflammatory drugs according to the needs of the disease; 4. Patients with multiple MRI examinations of the sacroiliac joint; 5. Patients with multiple disease activity scores.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to TNFi; 2. Patients with active hepatitis B, tuberculosis and other infectious diseases; 3. Pregnant patients; 4. Patients with severe infections.

Design outcomes

Primary

MeasureTime frame
disease activity and magnetic resonance imaging of sacroiliac joints;

Countries

China

Contacts

Public ContactDong Lingli

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

tjhdongll@163.com+86 18672912727

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026